Cite
MLA Citation
EC Keystone et al.. “SAT0155 Adalimumab in combination with non-methotrexate conventional synthetic disease modifying rheumatic drugs in a clinical trial setting.” Annals of the rheumatic diseases, vol. 76, n.d., p. 828. http://access.bl.uk/ark:/81055/vdc_100135159965.0x000063